Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma

被引：0
|
作者：
Se Hoon Park
Yuna Lee
Sang Hoon Han
So Young Kwon
Oh Sang Kwon
Sun Suk Kim
Ju Hyun Kim
Yeon Ho Park
Jeong Nam Lee
Soo-Mee Bang
Eun Kyung Cho
Dong Bok Shin
Jae Hoon Lee
机构：
[1] Department of Medicine,Division of Hematology and Oncology
[2] Gachon Medical School Gil Medical Center,Division of Gastroenterology
[3] Department of Medicine,Department of General Surgery
[4] Gachon Medical School Gil Medical Center,undefined
[5] Gachon Medical School Gil Medical Center,undefined
来源：
BMC Cancer | / 6卷
关键词：
Doxorubicin; Capecitabine; Bortezomib; Gastric Variceal Bleeding; Triplet Combination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: A retrospective study
    Edeline, Julien
    Raoul, Jean-Luc
    Vauleon, Elodie
    Guillygomach, Anne
    Boudjema, Karim
    Boucher, Eveline
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (06) : 713 - 716
  • [22] Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience
    Guo, Qiaojuan
    Chen, Mengwei
    Xu, Hanchuan
    Lu, Tianzhu
    Zhou, Han
    Chen, Yanyan
    Zong, Jingfeng
    Xu, Yun
    Chen, Bijuan
    Wang, Bingyi
    Zhu, Lili
    Pan, Jianji
    Lin, Shaojun
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 1387 - 1396
  • [23] Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy
    Peng, Pei-Jian
    Ou, Xue-Qing
    Chen, Zhi-Bin
    Liao, Hai
    Peng, Yu-Long
    Wang, Si-Yang
    Zhang, Hong-Yu
    Lin, Zhong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (02) : 323 - 328
  • [24] Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy
    Pei-Jian Peng
    Xue-Qing Ou
    Zhi-Bin Chen
    Hai Liao
    Yu-Long Peng
    Si-Yang Wang
    Hong-Yu Zhang
    Zhong Lin
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 323 - 328
  • [25] A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer
    Cho, EK
    Lee, WK
    Im, SA
    Lee, SN
    Park, SH
    Bang, SM
    Park, DK
    Park, YH
    Shin, DB
    Lee, JH
    ONCOLOGY, 2005, 68 (4-6) : 333 - 340
  • [26] Retrospective Comparative Study between Gemcitabine/Cisplatin and Gemcitabine/Capecitabine in the Treatment of Metastatic Carcinoma of Gallbladder
    Poddar, Soumita
    Mondal, Santu
    Chakraborty, Amitabha
    Dutta, Bodhisattwa
    CLINICAL CANCER INVESTIGATION JOURNAL, 2018, 7 (01): : 9 - 13
  • [27] Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma
    Waters, JS
    Moss, C
    Pyle, L
    James, M
    Hackett, S
    A'Hern, R
    Gore, M
    Eisen, T
    BRITISH JOURNAL OF CANCER, 2004, 91 (10) : 1763 - 1768
  • [28] Capecitabine for treatment of advanced hepatocellular carcinoma
    von Delius, S.
    Lersch, C.
    Mayr, M.
    Stock, K.
    Schulte-Frohlinde, E.
    Schmid, R. M.
    Eckel, F.
    HEPATO-GASTROENTEROLOGY, 2007, 54 (80) : 2310 - 2314
  • [29] Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma
    J S Waters
    C Moss
    L Pyle
    M James
    S Hackett
    R A'Hern
    M Gore
    T Eisen
    British Journal of Cancer, 2004, 91 : 1763 - 1768
  • [30] Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma
    Yoh, K
    Goto, K
    Ishii, G
    Niho, S
    Ohmatsu, H
    Kubota, K
    Kakinuma, R
    Nagai, K
    Suga, M
    Nishiwaki, Y
    CANCER, 2003, 98 (05) : 926 - 931
12345